The Gut Microbiota from Lean and Obese Subjects Contribute Differently to the Fermentation of Arabinogalactan and Inulin

PLoS One. 2016 Jul 13;11(7):e0159236. doi: 10.1371/journal.pone.0159236. eCollection 2016.

Abstract

Background: An aberrant metabolic activity or a compositional alteration of the gut microbiota has been proposed as a factor that makes us more prone to disease. Therefore, we explored the effect of two dietary fibers (arabinogalactan and inulin) on the microbiota from lean and obese subjects during 72 h in vitro fermentation experiments using the validated TNO dynamic in vitro model of the proximal colon: TIM-2. Metabolically, arabinogalactan fermentation showed a higher production of propionate when compared to n-butyrate in the obese microbiota fermentations. In general, lean microbiota produced more n-butyrate from the fermentation of both substrates when compared to the obese microbiota. Furthermore, the obese microbiota extracted more energy from the fermentation of both fibers.

Results: Compositionally, bacteria belonging to Gemmiger, Dorea, Roseburia, Alistipes, Lactobacillus and Bifidobacterium genera were found to be highly abundant or stimulated by the prebiotics in the lean microbiota suggesting a potential role in leanness. Furthermore, a significant correlation between known butyrogenic strains including B. adolescentis, an unclassified Bifidobacterium and F. prausnitzii with this metabolite in the fermentation of inulin in both microbiotas was found.

Conclusions: Although supplementary in vivo studies are needed, the current study provides more evidence for the consumption of specific ingredients with the aim of modulating the gut microbiota in the context of obesity.

MeSH terms

  • Acetates / metabolism
  • Adult
  • Bifidobacterium / genetics
  • Bifidobacterium / isolation & purification
  • Bifidobacterium / metabolism
  • Butyrates / metabolism*
  • Dietary Fiber / metabolism*
  • Energy Metabolism / physiology
  • Female
  • Fermentation
  • Galactans / metabolism*
  • Gastrointestinal Microbiome / genetics*
  • Humans
  • Inulin / metabolism*
  • Lactobacillus / genetics
  • Lactobacillus / isolation & purification
  • Lactobacillus / metabolism
  • Male
  • Obesity / metabolism*
  • Prebiotics / analysis
  • Propionates / metabolism*
  • RNA, Ribosomal, 16S / genetics
  • Valerates / metabolism

Substances

  • Acetates
  • Butyrates
  • Dietary Fiber
  • Galactans
  • Prebiotics
  • Propionates
  • RNA, Ribosomal, 16S
  • Valerates
  • Inulin
  • propionic acid
  • arabinogalactan

Grant support

This study was partly funded by the Top Institute Food & Nutrition (GH004; TIFN, Wageningen, The Netherlands). Carlota Bussolo de Souza received a scholarship from CNPq (National Council for Scientific and Technological Development) – Brazil – under the Program “Science without Borders” (grant number 246027/2012-6). Koen Venema is chief executive officer of Beneficial Microbes Consultancy. TIFN provided support in the form of salaries for authors KV and MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.